vancomycin has been researched along with Boils in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habib, A; Qadir, A | 1 |
| KOENIG, MG | 1 |
1 review(s) available for vancomycin and Boils
| Article | Year |
|---|---|
THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS.
Topics: Animals; Anti-Bacterial Agents; Antitoxins; Bacitracin; Carrier State; Erythromycin; Furunculosis; Humans; Immune Sera; Immunotherapy, Active; Methicillin; Novobiocin; Osteomyelitis; Penicillins; Probenecid; Staphylococcal Infections; Toxicology; Toxins, Biological; Vancomycin | 1963 |
1 other study(ies) available for vancomycin and Boils
| Article | Year |
|---|---|
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |